“Assessment of Pentraxin 3 (PTX3) and Sclerostin (SOST) Levels in Serum of Patients with Chronic Kidney Disease” (2021) Medico Legal Update, 21(2), pp. 1274–1280. doi:10.37506/mlu.v21i2.2866.